908 Devices Inc. (MASS)

Market Cap	238.48M
Revenue (ttm)	63.99M
Net Income (ttm)	-17.69M
Shares Out	35.86M
EPS (ttm)	-0.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	247,177
Open	6.70
Previous Close	6.61
Day's Range	6.60 - 6.91
52-Week Range	1.81 - 8.06
Beta	0.38
Analysts	Buy
Price Target	5.33 (-19.85%)
Earnings Date	Aug 5, 2025

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 18, 2020
• Employees: 246
• Stock Exchange: NASDAQ
• Ticker Symbol: MASS
• Website: https://908devices.com

Financial Performance

In 2024, 908 Devices's revenue was $59.63 million, an increase of 18.72% compared to the previous year's $50.23 million. Losses were -$72.21 million, 98.4% more than in 2023.

Analyst Summary

According to 3 analysts, the average rating for MASS stock is "Buy." The 12-month stock price target is $5.33, which is a decrease of -19.85% from the latest price.

Price Target

$5.33

(-19.85% downside)

Analyst Consensus: Buy